ArticleCureus2025
A Challenging Uncommon Presentation of Steroid-Resistant Tumefactive Multiple Sclerosis: A Brainstem Crisis Resolved With Plasma Exchange and Ocrelizumab Maintenance.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tumefactive multiple sclerosis (TMS) is a rare variant of multiple sclerosis that presents large demyelinating lesions, often mimicking neoplasms or stroke. We report the case of a 32-year-old man who presented with progressive right-sided weakness, facial involvement and cranial nerve deficits. Neuroimaging revealed a demyelinating lesion in the left pons with additional older plaques. Despite initial treatment with high-dose corticosteroids, the patient showed no improvement. Subsequent plasma exchange led to significant neurological recovery and ocrelizumab was initiated for relapse prevention. This case highlights the diagnostic challenge of TMS presenting as a brainstem syndrome and the effective role of plasma exchange followed by ocrelizumab maintenance therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.